Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2007-7-4
pubmed:abstractText
The conventional replacement therapy in Addison's disease (AD) does not restore the normal diurnal cortisol rhythm. We explored the feasibility and safety of continuous s.c. hydrocortisone infusion (CSHI) as a novel mode of glucocorticoid replacement therapy.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0804-4643
pubmed:author
pubmed:issnType
Print
pubmed:volume
157
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
109-12
pubmed:dateRevised
2009-6-8
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Continuous subcutaneous hydrocortisone infusion in Addison's disease.
pubmed:affiliation
Division of Endocrinology, Institute of Medicine, University of Bergen, Norway. kristian.lovas@med.uib.no
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't